Last reviewed · How we verify
NANOS1 , argent colloïdal ,
Colloidal silver exerts antimicrobial effects through direct interaction with bacterial and fungal cell membranes and nucleic acids.
Colloidal silver exerts antimicrobial effects through direct interaction with bacterial and fungal cell membranes and nucleic acids. Used for Bacterial or fungal infections (specific indication unclear from available information).
At a glance
| Generic name | NANOS1 , argent colloïdal , |
|---|---|
| Sponsor | General Administration of Military Health, Tunisia |
| Drug class | Colloidal metal nanoparticle |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Antimicrobial |
| Phase | Phase 3 |
Mechanism of action
Colloidal silver (argent colloïdal) consists of silver nanoparticles suspended in a liquid medium. These particles are believed to disrupt microbial cell walls, inhibit enzyme function, and interfere with DNA replication in bacteria and fungi. The exact mechanism in human therapeutic use remains incompletely characterized, particularly for systemic applications.
Approved indications
- Bacterial or fungal infections (specific indication unclear from available information)
Common side effects
- Argyria (blue-gray skin discoloration)
- Gastrointestinal disturbance
- Allergic reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |